en

PRODUCT DETAIL

Remicade 100 mg prášok na prípravu infúzneho koncentrátu

Code 13333
MA number EU/1/99/116/003
Product Form: plc ifc 3x100 mg (liek.inj.skl.)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
MAH, country: Janssen Biologics B.V., Netherland
Therapeutic Class: 59 - IMMUNOPRAEPARATA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L04 Immunosuppressants
L04A Immunosuppressants
L04AB Tumor necrosis factor alpha (TNF-alpha) inhibitors
L04AB02 Infliximab
Shelf life: 36
Container: glass vial
Route of admin.: Intravenous use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 8(3) application
MA issued: 13.08.1999
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 19.06.2018
eu-flag.png sk-flag.png